Multimodal AI Enterprise Adoption Is Now the Default

Your next vendor RFP just changed shape. Multimodal AI enterprise adoption is no longer a checkbox feature you evaluate after picking a model, it’s the baseline architecture assumption you build the RFP around. Gartner says 80% of enterprise software will be multimodal by 2030, up from under 10% in 2024. That’s not a slow curve. That’s a rewrite of procurement criteria happening while most teams are still finishing their 2026 roadmap.

Here’s the tension nobody’s resolving cleanly: the same month frontier labs pushed multimodal models to mass-market default pricing, a peer-reviewed study in Nature Medicine found those same models reasoning incorrectly under adversarial testing, even when they landed on the right answer. Adoption and reliability are moving on different timelines. This piece is about both, because you can’t plan around one without the other.

The adoption curve, in Gartner’s own numbers

Gartner has now published two forecasts, a year apart, that both point the same direction. In September 2024, Distinguished VP Analyst Erick Brethenoux told the Gartner IT Symposium that 40% of generative AI solutions would be multimodal by 2027, up from just 1% in 2023. By July 2025, the firm went further: 80% of enterprise software and applications will be multimodal by 2030, up from less than 10% in 2024, according to Senior Director Analyst Roberta Cozza.

Multimodal is a fundamental transformation, letting AI shift from supporting individual productivity to proactive, contextual decision intelligence across healthcare, finance, and manufacturing.

Roberta Cozza, Senior Director Analyst, Gartner · Gartner press release, July 2025

Note the small inconsistency across Gartner’s own materials: some releases cite the 2024 baseline as “less than 5%,” others say “less than 10%.” Neither figure changes the shape of the curve, but it’s worth knowing the exact baseline moves depending on which Gartner document you’re reading.

Real-world numbers back the direction, if not the pace. Two recent frontier releases landed within a day of each other on June 30, 2026: Anthropic’s Claude Sonnet 5 became the default model for every free and paid Claude user starting July 1, and Google shipped two new multimodal image models, Gemini 3.1 Flash Image and Gemini 3 Pro Image, through Google AI Studio. Neither company is treating multimodal as a premium add-on anymore. It’s the base tier.

Why enterprises are consolidating around multimodal now

Picture a claims adjuster at a mid-size insurer. Five years ago, that job meant one tool for reading the intake form, another for the damage photos, a third for the call transcript, and a spreadsheet to stitch it all together. Multimodal AI enterprise adoption promises to collapse that into one system that reads the form, looks at the photo, and listens to the call in the same pass. That’s the pitch, and it’s why McKinsey found 88% of organizations now use AI in at least one business function, with generative AI use jumping to 72% from just 33% in 2024.

But adoption and scale are different claims. The same McKinsey survey found nearly two-thirds of organizations haven’t started scaling AI across the enterprise. Most of what gets counted as “multimodal adoption” in market surveys is still pilots, not production.

According to Distinguished VP Analyst Erick Brethenoux, the case for native multimodal architecture is structural: real-world data was never single-format to begin with, and stitching together separate vision, audio, and text models introduces latency and accuracy problems that a unified model avoids.

The Nature Medicine problem: benchmarks lie

Here’s the part the vendor decks leave out. A peer-reviewed study published in Nature Medicine in June 2026, “Evaluating the robustness and readiness of large frontier models in health AI applications,” stress-tested frontier multimodal models, including GPT-5, Claude 3.5, and Gemini 2.5 Pro, on multimodal medical reasoning tasks. Researchers used adversarial perturbations, removing key details from an image or swapping which modality carried the critical information, and found the models frequently reached the correct answer for the wrong reasons. That means faulty reasoning, inappropriate shortcuts, and outright hallucinations were hiding behind passing benchmark scores.

One caveat worth flagging for readers who follow this closely: by the time a peer-reviewed paper like this clears review, the exact models it tested are often a generation behind whatever just shipped. That’s a structural limitation of academic AI evaluation, not evidence the newest models are automatically safer. Treat it as a reason for more testing, not less.

The contrarian read: Gary Marcus and the ROI gap

Not everyone is buying the adoption-curve optimism, and it’s worth hearing the strongest version of that case. NYU professor emeritus and longtime AI reliability critic Gary Marcus has argued for months that generative and multimodal systems remain fundamentally unreliable regardless of which lab built them, and that reported enterprise ROI hasn’t come close to matching the capital poured into these systems.

The industry keeps converging on models with essentially the same class of reasoning flaws, no matter how much scale you throw at them, and the spending-to-revenue gap tells its own story.

Gary Marcus, cognitive scientist and NYU professor emeritus · Marcus on AI, June 2026

Marcus has specifically pointed to the Nature Medicine findings as proof that frontier multimodal models “are not ready” for high-stakes reasoning, and he’s not alone in reading McKinsey’s own numbers as a warning sign rather than a victory lap. A companion 2025 McKinsey survey found more than 80% of respondents weren’t yet seeing measurable EBIT impact from generative AI. Adoption curve and value capture are two separate stories, and they get conflated constantly.

Our read: the skeptics aren’t wrong that governance is lagging. McKinsey’s 2026 AI Trust Maturity Survey put the average Responsible-AI maturity score at just 2.3 out of a possible higher band, up only slightly from 2.0 in 2025, with roughly a third of organizations scoring 3 or above on strategy and agentic-AI governance. Capability is outrunning oversight, and that gap is exactly where the Nature Medicine failures live.

What this means for your stack

If you’re the one signing off on the next platform migration, three things follow directly from the research above:

• Assume multimodal ingestion by default. Document, image, audio, and video inputs should be evaluation criteria from day one of any vendor RFP, not a phase-two add-on.
• Match the use case to the confidence level. Practitioner reporting from July 2026 converges on the same lesson: multimodal pays off in high-friction, measurable workflows like support tickets with screenshots or full-coverage compliance QA, not in low-stakes novelty pilots.
• Fund governance at the same pace as capability. If your Responsible-AI maturity score would land near McKinsey’s 2.3 average, that’s your signal to slow autonomous, unsupervised deployment in regulated domains until review processes catch up. NeuralWired’s own reporting on AI code review adoption found a similar pattern: capability scaling faster than the human oversight built to catch its mistakes.

There’s precedent for how this plays out badly. Gartner has separately warned that more than 40% of agentic AI projects will be abandoned by 2027 over cost, unclear value, or inadequate risk controls, and NeuralWired’s reporting on AI agent deployment failures found roughly 70% of agent projects never reach production. Multimodal rollouts are highly likely to follow the same adoption-curve-versus-production-reality gap.

Frequently asked questions

What to watch next

The honest version of this story has two halves that both hold up under scrutiny. Gartner’s forecasts describe real, well-documented product availability: multimodal is becoming the default architecture, not a premium tier. The Nature Medicine findings describe something different and equally real: benchmark performance and production-grade reliability are not the same claim, and right now the evidence for the second one is thinner than the marketing around the first.

Over the next 6 to 18 months, watch three things. First, whether McKinsey’s Responsible-AI maturity scores climb faster than the 2.0-to-2.3 pace they’ve shown so far, since that gap is what’s actually gating safe deployment. Second, whether the next generation of academic evaluation catches up to model release cycles, so reliability claims stop lagging capability claims by a full peer-review cycle. Third, whether the 40%+ agentic-AI-project abandonment rate Gartner is forecasting for 2027 repeats itself in multimodal rollouts specifically, or whether the sector learns from the agentic AI stumble first.

None of that means wait. It means build for the workflows where multimodal already earns its cost, and keep governance funded at the same pace as capability.